Labcorp Holdings Indefinite- lived intangible impairment increased by 1.5% to $5.98B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $5.51B to $5.98B. Over 5 years (FY 2020 to FY 2025), Indefinite- lived intangible impairment shows relatively stable performance with a -0.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in impairment charges signals a decline in the value of the company's intangible assets, potentially indicating poor acquisition outcomes or changing market conditions.
This represents the gross value of indefinite-lived intangible assets, excluding goodwill, that have been subject to imp...
Varies significantly based on M&A history; companies with frequent acquisitions often show higher volatility in this metric.
other_intangible_assets_gross_excluding_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.04B | $6.12B | $5.42B | $5.71B | $5.64B | $5.63B | $4.59B | $5.89B | $4.74B | $4.91B | $5.06B | $5.15B | $5.15B | $5.44B | $5.43B | $5.51B | $5.63B | $5.77B | $5.89B | $5.98B |
| QoQ Change | — | +1.4% | -11.4% | +5.2% | -1.1% | -0.3% | -18.4% | +28.3% | -19.6% | +3.5% | +3.1% | +1.8% | +0.0% | +5.7% | -0.2% | +1.4% | +2.1% | +2.5% | +2.0% | +1.5% |
| YoY Change | — | — | — | — | -6.6% | -8.1% | -15.3% | +3.3% | -16.0% | -12.8% | +10.1% | -12.6% | +8.7% | +10.9% | +7.4% | +7.0% | +9.3% | +6.0% | +8.3% | +8.5% |